AbbVie · 15 hours ago
Senior Scientist I, Cell/Molecular Biology
Irvine, CA
Full-time
Onsite
Senior Level
$94K/yr - $178K/yr
6+ years expAbbVie is a company dedicated to discovering and delivering innovative medicines and solutions for serious health issues. They are seeking a Senior Scientist I to lead scientific initiatives in the Toxins group, focusing on the development of bioassays for analytical testing in biological toxin products.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Lead scientific initiatives by generating innovative technical ideas and strategic approaches to advance research objectives and overcome experimental challenges
Demonstrate a strong understanding of project goals, aligning research activities with broader objectives and adapting experimental plans as needed based on new data, project developments, or shifting priorities
Independently design, execute, and interpret complex experiments with rigorous methodology to ensure reproducibility and accurate data interpretation. Develop, optimize, and implement novel experimental protocols by leveraging emerging technologies to drive scientific progress and solve technical issues
Maintain advanced, up-to-date expertise in relevant scientific and technical disciplines, applying this knowledge to experimental design, troubleshooting, method development, and integration of best practices from current literature
Establish and manage clear experimental timelines, closely tracking progress and ensuring timely completion of project deliverables through strong organizational and time-management skills
Deliver high-quality scientific communication by drafting and editing SOPs, technical reports, publications, presentations, and patent applications according to industry and regulatory standards. Effectively organize, analyze, and present scientific ideas and experimental data to cross-functional teams and stakeholders through impactful written and oral communications
Qualification
Required
Advanced degree in a relevant field: Ph.D. (with 6+ months biopharmaceutical industry experience preferred), Master's degree (6+ years industry experience) and Bachelor's degree (8+ years industry experience) in Cell and Molecular Biology, Biochemistry, Biochemical or Biomedical Engineering, Biotechnology, or closely related disciplines
Robust research background in neuroscience, with direct expertise in neural cancer cell and primary cell culture, 3D cell models, and complex co-culture systems
Demonstrated hands-on experience in developing and optimizing these models for scientific study or drug discovery applications
Proficient in RNA microinjection for protein expression and functional evaluations, with a solid understanding of related molecular techniques
Experienced in the generation of stable cell lines and the design and execution of novel cell-based assays
Highly skilled in high-resolution imaging and live-cell imaging techniques, including advanced confocal microscopy, fluorescence-based assays, and related methodologies for monitoring cellular processes in real time
Extensive laboratory experience with molecular cloning, mammalian cell culture, PCR, Western blotting, cell sorting, bioassays, advanced microscopy, transfection procedures, HPLC, and mass spectrometry
Knowledgeable in genome editing approaches—including CRISPR/Cas9—with a thorough understanding of design, execution, and validation of gene editing experiments
Demonstrated proficiency in computer skills essential for scientific research, including word processing, spreadsheets, presentation software, and advanced data analysis
Capable of analyzing, interpreting, and presenting complex data sets using specialized scientific software (e.g., Python, R, JMP)
Proven scientific leadership, demonstrated by being the main author on published research papers and holding patents
Skilled at designing experiments, solving problems creatively, developing thorough experimental plans, and independently troubleshooting and validating results
Demonstrated ability to stay current with scientific advances, critically assess relevant literature, and quickly integrate emerging concepts and techniques into research projects
Detail-oriented work style, with a proven record of delivering high-quality and reproducible data within tight timelines
Strong interpersonal and collaborative skills, enabling effective teamwork within multidisciplinary, cross-functional teams
Able to communicate complex scientific information clearly through both spoken presentations and technical documentation
Self-motivated and adaptable, with a passion for scientific discovery and a commitment to continuous learning and process improvement
Preferred
6+ months biopharmaceutical industry experience preferred for Ph.D. candidates
Robust research background in neuroscience, with direct expertise in neural cancer cell and primary cell culture, 3D cell models, and complex co-culture systems preferred
Previous GxP experience and attention to detail in documentation preferred
Experience with laboratory automation platforms (such as Hamilton) is highly desirable
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-16
Company data provided by crunchbase